Errata  by unknown
In the August 2001 issue of the journal (117:2, 318±325) the acknowledgements were incomplete. The full acknowledgements should
be:
The authors acknowledge the generous support of StallergeÁne, Fresnes, France and the ``DeÂleÂgation aÁ la Recherche du CHU de
Montpellier''.
The authors apologise for any inconvenience this may have caused.
In the August issue of the journal (117:2, 394) abstract 027 of the 62nd Annual Meeting of the Society for Investigative Dermatology
was printed with the authors in the wrong order. The correct order of the authors should be:
R. Caldelari, A. de Bruin, D. Baumann, M. Suter, T. Hunziker, and E. MuÈller
Blackwell Publishing apologise for any inconvenience this may have caused.
In the August issue of the journal (117:2, 365±370) Table III was printed incorrectly. The correct Table III is given below:
Table III. Type of p53 mutations detected in BCC from PUVA-treated psoriasis patients
Tumor Exon Codon Base change Surrounding sequence Type of Amino acid
(5¢®3¢)a mutationb change
A1 4 75 C®T g c c c C t g c a UV Pro®Leu
A1 4 88 C®T c c a g C c c c c UV Ala®Val
A1 4 94 C®T c t g t C a t c t UV/PUVA Ser®Leu
A1 5 144 C®A c a g C t g c a c Other Gln®His
A2 5 155 C®T g g c a c C c g c (UV) None
A2 5 165 C®T a a g C a g t c a PUVA Gln®Stop
A3 4 67 C®T a t g c C a g a g UV/PUVA Pro®Leu
A3 4 82 C®T a c a c C g g c g UV Pro®Leu
A3 4 84 C®T g c g g C c c c t UV Ala®Val
A3 4 88 C®T c c a g C c c c c UV Ala®Val
A3 4 92 C®T t g g c c C c t g (UV) None
A3 5 177 C®T t g c c c C c a c (UV) None
A4 5 177 CC®TT t g c c CC c a c UV Pro®Leu
D1 9 317 C®T c c c C a g c c a UV/PUVA Gln®Stop
E2 7 229 T®A g a c T g t a c c PUVA Cys®Ser
E3 4 122 C®G a g t C a c a g a (PUVA) None
E3 7 234 T®C c a c T a c a a c PUVA Tyr®His
aThe 5¢®3¢ sequence is shown for the strand (transcribed or nontranscribed) containing the pyrimidine(s). Mutated bases are shown in bold. Multi- and
dipyrimidine sequences are underlined. 5¢-TpA:ApT and 5¢-TpG:ApC sequences are double underlined.
bUV-type mutations were de®ned as C®T and CC®TT transitions at dipyrimidines. PUVA-type mutations were de®ned as mutations at potential psoralen-
binding sites 5¢-TpA:ApT and 5¢-TpG:ApC. Silent mutations are shown in parenthesis.
Blackwell Publishing apologise for any inconvenience this may have caused.
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